Paniculitis pancreática como forma de presentación inicial de adenocarcinoma gástrico con metástasis hepáticas

Aznar-Oroval, Eduardo; lllueca-Ballester, Carmen; Sanmartín-Jiménez, Onofre; Martínez-Lapiedra, Carmen; Santos-Corés, Jesús
January 2013
Revista Española de Patología;ene-mar2013, Vol. 46 Issue 1, p40
Academic Journal
A patient presenting with a ten month history of progressive lower limb panniculitis was found to have more than 7,000 lipase U/L. Pancreatic panniculitis and gastric adenocar-cinoma with liver metastases was diagnosed, despite no clinical or radiological findings of pancreatic disease. Pancreatic panniculitis arising from a non pancreatic primary is extremely rare. To our know-ledge, this is the first time pancreatic panniculitis has been reported as the presenting sign of gastric carcinoma with hepatic metastases. It is also the longest survival to be reported to date.


Related Articles

  • Gastric Cancer Staging with Dual Energy Spectral CT Imaging. Pan, Zilai; Pang, Lifang; Ding, Bei; Yan, Chao; Zhang, Huan; Du, Lianjun; Wang, Baisong; Song, Qi; Chen, Kemin; Yan, Fuhua // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Purpose: To evaluate the clinical utility of dual energy spectral CT (DEsCT) in staging and characterizing gastric cancers. Materials and Methods: 96 patients suspected of gastric cancers underwent dual-phasic scans (arterial phase (AP) and portal venous phase (PP)) with DEsCT mode. Three...

  • Hepatic Lipoma: Radiological Imaging Findings. Koplay, Mustafa; Hacioglu, Alper; Algin, Mustafa Cem // Surgical Science;Sep2011, Vol. 2 Issue 7, p363 

    Hemangiomas and hepatic metastases are the leading reasons of echogenic masses on ultrasound (US) evaluation of the liver. Lipomas of the liver are extremely rare and have been sporadically reported in the literature during the last century. The present report describes a patient with hepatic...

  • P-0107THE IMPACT OF POSTOPERATIVE CHEMORADIOTHERAPY ON SURVIVAL IN RESECTABLE GASTRIC CANCER. Potrc, Stojan; Godec, Manca; Gajzer, Borut // Annals of Oncology;Jun2013, Vol. 24 Issue suppl_4, piv66 

    No abstract available.

  • Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib. Zhu, Andrew X.; Kudo, Masatoshi; Assenat, Eric; Cattan, Stéphane; Yoon-Koo Kang; Ho Yeong Lim; Poon, Ronnie T. P.; Blanc, Jean-Frederic; Vogel, Arndt; Chao-Long Chen; Dorval, Etienne; Peck-Radosavljevic, Markus; Santoro, Armando; Daniele, Bruno; Furuse, Junji; Jappe, Annette; Perraud, Kevin; Anak, Oezlem; Sellami, Dalila B.; Li-Tzong Chen // JAMA: Journal of the American Medical Association;7/2/2014, Vol. 312 Issue 1, p57 

    IMPORTANCE Aside from the multikinase inhibitor sorafenib, there are no effective systemic therapies for the treatment of advanced hepatocellular carcinoma. OBJECTIVE To assess the efficacy of everolimus in patients with advanced hepatocellular carcinoma for whom sorafenib treatment failed....

  • Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. Kanda, Tatsuo; Yajima, Kazuhito; Kosugi, Shin-ichi; Ishikawa, Takashi; Ajioka, Yoichi; Hatakeyama, Katsuyoshi // Gastric Cancer;Jul2012, Vol. 15 Issue 3, p235 

    Background: Current advances in chemotherapy provide opportunities for stage IV gastric cancer patients with distant metastasis to undergo potentially curable resection. There are, however, few data on gastrectomy as a secondary surgery aimed at rendering such patients cancer-free. Methods: We...

  • Alpha-Fetoprotein-Producing Early Gastric Cancer of the Remnant Stomach: Report of a Case. Yutaka Shibata; Kouhei Sato; Masashi Kodama; Hiroshi Nanjyo // Surgery Today;Nov2007, Vol. 37 Issue 11, p995 

    Abstract  A 67-year-old man initially underwent a distal gastrectomy for early gastric cancer (T1, N0, M0; Stage IA) in March 1995. During the follow-up period, an elevation of the serum α-fetoprotein (AFP) level (98.8 ng/ml) and a liver tumor (S4) were detected. A left...

  • Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy. Snyder, R. A.; Castaldo, E. T.; Bailey, C. E.; Phillips, S. E.; Chakravarthy, A. B.; Merchant, N. B. // International Journal of Surgical Oncology;2012, p1 

    Purpose. Although randomized trials suggest a survival benefit of adjuvant chemotherapy and radiation therapy (XRT) for gastric adenocarcinoma, its use in patients who undergo an extended lymphadenectomy is less clear. The purpose of this study was to determine if a survival benefit exists in...

  • P-0023GASTRIC CANCER IN THE PODKARPACIE REGION BETWEEN 1990 AND 2010. Gawelko, Jan // Annals of Oncology;Jun2013, Vol. 24 Issue suppl_4, piv43 

    No abstract available.

  • A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy. Kim, Yeul; Muro, Kei; Yasui, Hirofumi; Chen, Jen-Shi; Ryu, Min-Hee; Park, Se-Hoon; Chu, Kent-Man; Choo, Su-Pin; Sanchez, Teresa; DelaCruz, Christine; Mukhopadhyay, Pralay; Lainas, Ioannis; Li, Chung-Pin // Cancer Chemotherapy & Pharmacology;Oct2012, Vol. 70 Issue 4, p583 

    Purpose: The highest rates of gastric cancer occur in Eastern Asia. Fluoropyrimidine-based therapy is used initially in unresectable and metastatic disease, but no single standard of care exists following disease progression. Ixabepilone, an epothilone B analog, is a non-taxane...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics